LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Vorinostat | 3.1623 | 17.99 | 84.90 | 4 | 898 | 0.0044 | -0.5924 | MN20160318_Q02 | G21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 17.99 | 84.90 | 4 | 898 | 0.0044 | -0.5924 | MN20160318_Q02 | G13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Neratinib | 1 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | J12 |
| MCF 10A-H2B-mCherry | Alpelisib | 1 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | J19 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | K13 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Etoposide | 1 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | E13 |
| MCF 10A-H2B-mCherry | Alpelisib | 10 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | G20 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.01 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | C12 |
| MCF 10A-H2B-mCherry | Etoposide | 0.0010833 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | E15 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.1 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | H07 |
| MCF 10A-H2B-mCherry | Vorinostat | 10 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | L19 |
| MCF 10A-H2B-mCherry | Vorinostat | 0.031667 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | D10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.88 | 84.90 | 8 | 531 | 0.0151 | -0.5906 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 9.47 | 84.90 | 10 | 447 | 0.0224 | -0.5902 | MN20160318_Q02 | F22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | G14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.1 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | I13 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.018 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | F19 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | E18 |